GT
AGN

Glenview Trust’s Allergan plc AGN Stock Holding History

Glenview Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,848
Closed -$504K – 342
2020
Q1 		$504K Sell
2,848
-87
-3% -$16.4K 0.04% 208
2019
Q4 		$561K Sell
2,935
-99
-3% -$17.9K 0.03% 224
2019
Q3 		$511K Buy
3,034
+414
+16% +$67.4K 0.03% 236
2019
Q2 		$438K Buy
2,620
+40
+2% +$5.54K 0.03% 247
2019
Q1 		$377K Sell
2,580
-230
-8% -$33.3K 0.02% 259
2018
Q4 		$376K Buy
2,810
+350
+14% +$57.4K 0.03% 249
2018
Q3 		$469K Buy
2,460
+32
+1% +$5.88K 0.03% 240
2018
Q2 		$405K Sell
2,428
-17
-0.7% -$2.73K 0.03% 229
2018
Q1 		$411K Sell
2,445
-5,826
-70% -$977K 0.03% 250
2017
Q4 		$1.35M Sell
8,271
-22,457
-73% -$4.03M 0.09% 153
2017
Q3 		$6.3M Buy
30,728
+1,840
+6% +$428K 0.46% 78
2017
Q2 		$7.02M Buy
28,888
+2,747
+11% +$646K 0.55% 64
2017
Q1 		$6.25M Buy
26,141
+8,550
+49% +$1.99M 0.49% 72
2016
Q4 		$3.69M Buy
+17,591
New +$3.64M 0.31% 90
2015
Q4 		$7.19M Buy
+22,999
New +$6.85M 0.75% 46
2014
Q4 		$794K Buy
+3,084
New +$771K 0.08% 126
2013
Q4 		$280K Buy
+1,667
New +$261K 0.03% 192

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Glenview Trust's AGN Position: Q2 2020 in Review

Glenview Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,848 shares — an estimated $504K sold.

Glenview Trust first reported a position in AGN in Q4 2013 and held it in 17 quarters. The position peaked at $7.19M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Glenview Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Glenview Trust sold 2,848 Allergan plc shares in Q2 2020, an estimated $504K.
  • Glenview Trust first reported a position in Allergan plc in Q4 2013 and held it in 17 quarters.
  • Glenview Trust's Allergan plc position peaked at $7.19M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Glenview Trust's 13F filing for Q2 2020, filed 12 Aug 2020.